Basic observation:
a. Between 2020 and now Sun Pharma has grown 131%. The last time it showed such considerable growth was between 2013 and 2014 where it grew by 166%.
b. Post having a falling trendline for 59 months (-74.15%) it has been within a rising channel for over 16 months (108%).
c. RSI and KST currently showing positive signs
d. Prices have been consolidating for for 56 days.
e. The price has currently surpassed the 46 days resistance
f. In daily time frame, 10 and 20 DMA have cut above 50 DMA and positive movement has begun. DMA's in order when used in Monthly and Weekly time frame too.
g. Currently Trading at 703.40
Entry @ 703.80
Target @709.45
Stoploss @ 701.94 (-1.86)
Risk to Reward Ratio @ 3.03
a. Between 2020 and now Sun Pharma has grown 131%. The last time it showed such considerable growth was between 2013 and 2014 where it grew by 166%.
b. Post having a falling trendline for 59 months (-74.15%) it has been within a rising channel for over 16 months (108%).
c. RSI and KST currently showing positive signs
d. Prices have been consolidating for for 56 days.
e. The price has currently surpassed the 46 days resistance
f. In daily time frame, 10 and 20 DMA have cut above 50 DMA and positive movement has begun. DMA's in order when used in Monthly and Weekly time frame too.
g. Currently Trading at 703.40
Entry @ 703.80
Target @709.45
Stoploss @ 701.94 (-1.86)
Risk to Reward Ratio @ 3.03
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.